Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/14/2009EP2108365A1 Single dosage pharmaceutical formulation comprising eprosartan mesylate
10/14/2009EP2108362A2 Method of producing a cationic liposomal preparation comprising a lipophilic compound
10/14/2009EP2108360A2 Topical Pharmaceutical Foam Composition
10/14/2009EP2108359A1 Warming and nonirritating lubricant compositions
10/14/2009EP2108020A2 1-h-pyrazolo[3,4b]pyrimidine derivatives and their use as modulators of mitotic kinases
10/14/2009EP2108019A2 1-h-pyrazolo[3,4b]pyrimidine derivatives and their use as modulators of mitotic kinases
10/14/2009EP2108018A2 8-oxa-1,4-diazaspiro [4,5] dec-3-en-1-yl and 1,4,8-triazaspiro [4,5] dec-3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
10/14/2009EP2108017A2 Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists
10/14/2009EP2108016A1 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors
10/14/2009EP2108015A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
10/14/2009EP2108013A2 Crystalline forms of deferasirox
10/14/2009EP2108012A2 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof
10/14/2009EP2107909A2 Compounds and pharmaceutical compositions for the treatment of liver disorders
10/14/2009EP2107908A2 Use of a trpm5 inhibitor to regulate insulin and glp-1 release
10/14/2009EP2107907A1 New combination for use in the treatment of inflammatory disorders
10/14/2009EP2107906A2 Novel therapeutic use for treating leukaemia
10/14/2009EP2107903A1 Pharmaceutical composition comprising a campothecin derivative
10/14/2009EP2107870A2 Improved reduced irritant enema for the treatment of inflammatory bowel disease (ibd)
10/14/2009EP1979360B1 Compounds and compositions as ppar modulators
10/14/2009EP1893603B1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
10/14/2009EP1877367B1 Acetylene derivatives
10/14/2009EP1863470B1 A method for preventing and/or treating vaginal and vulval infections
10/14/2009EP1856090B1 Substituted thiophene derivatives as glucagon receptor antagonists, preparation and therapeutic uses
10/14/2009EP1856082B1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors
10/14/2009EP1838670B1 Process for the preparation of carvedilol and its enantiomers
10/14/2009EP1833830B1 Quinoline derivative, use and production thereof, and drug containing the same
10/14/2009EP1819331B1 Combinations comprising epothilones and protein tyrosine kinase inhibitors and pharmaceutical uses thereof
10/14/2009EP1809639B1 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
10/14/2009EP1791537B1 3-arylthioindole-2-carboxamide derivatives and analogs thereof as inhibitors of casein kinase i
10/14/2009EP1786774B1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
10/14/2009EP1771420B1 Novel 2,6-diaminopyridine-3-one derivatives
10/14/2009EP1755604B1 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
10/14/2009EP1747002B1 New apiary veterinary composition
10/14/2009EP1740183B1 Novel use for pde5 inhibitors
10/14/2009EP1732569B1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
10/14/2009EP1729771B1 Pyridyl derivatives and their use as mglu5 receptor antagonists
10/14/2009EP1701722B1 N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy¨]pentoxy}benzamidine 2 methansulfonic acid salt
10/14/2009EP1658267B1 Inhibitors of cathepsin s
10/14/2009EP1636235B1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
10/14/2009EP1622897B1 Inhibitors of phosphatidylinositol 3-kinase
10/14/2009EP1599476B1 Novel diazabicyclic aryl derivatives
10/14/2009EP1594858B1 Novel benzoimidazole derivatives useful as antiproliferative agents
10/14/2009EP1534339B1 Topical anhydrous and ethanol-free pimecrolimus compositions
10/14/2009EP1494661B1 Ptx3 gene expression suppressing method
10/14/2009EP1483269B1 Racemization and enantiomer separation of clopidogrel
10/14/2009EP1474158B1 Prevention and treatment of oxidative stress disorders by compounds which elevate intracellular levels of glutathione or phase ii detoxification enzymes
10/14/2009EP1464331B9 Compressed oral pharmaceutical dosage form, with an enteric coating, which contains an acid-labile benzimidazole compound
10/14/2009EP1461337B1 Pyrido¬2,1-a isoquinoline derivatives as dpp-iv inhibitors
10/14/2009EP1432737B1 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
10/14/2009EP1410795B1 Remedies for allergic eye diseases
10/14/2009EP1397137B1 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/14/2009EP1390343B1 Novel retinoid derivatives and an anti-cancer pharmaceutical composition comprising said compounds
10/14/2009EP1337527B1 Indolylmaleimide derivatives as protein kinase c inhibitors
10/14/2009EP1180686B1 Remedies for kidney diseases and method for screening the same
10/14/2009EP1153129B1 Method of treating restenosis by antisense targeting of c-myc
10/14/2009EP1144447B1 Tuberculosis diagnostic test
10/14/2009EP1139793B1 Inhibitors of the bitter taste response
10/14/2009EP0941227B2 Epothilone d, production process, and its use as cytostatic as well as phytosanitary agent
10/14/2009CN101558157A Oligoribonucleotides and uses thereof
10/14/2009CN101558078A Macrolide compounds endowed with antiinflammatory activity
10/14/2009CN101558075A 5- [4- (azetidin-3-yl0xy) -phenyl] -2-phenyl-5h-thiaz0l0 [5,4-c] pyridin-4-0ne derivatives and their use as mch receptor antagonists
10/14/2009CN101558074A Epothilone analogues modified at positions C12-C13 as anticancer drugs
10/14/2009CN101558073A Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6h-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof
10/14/2009CN101558072A Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors
10/14/2009CN101558071A Substituted quinazolines
10/14/2009CN101558070A Triazolo-pyridazine protein kinase modulators
10/14/2009CN101558069A Cis-cyclohexyl substituted pyrimidinone derivatives
10/14/2009CN101558068A Phenylacetamides useful as protein kinase inhibitors
10/14/2009CN101558067A 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as MTOR inhibitors
10/14/2009CN101558066A Pyrrole derivatives with antibacterial activity
10/14/2009CN101558065A Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
10/14/2009CN101558064A Sulfonyl-phenyl-2h-[1,2,4]oxodiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals
10/14/2009CN101558063A Compositions of azimilide dihydrochloride
10/14/2009CN101558062A Indolylmaleimide derivatives as kinase inhibitors
10/14/2009CN101558061A Process for preparing a crystalline form of candesartan cilexetil
10/14/2009CN101558060A Piperidine derivative used for treating chemokine receptor 5 mediated diseases
10/14/2009CN101558059A Hepatitis C virus inhibitors
10/14/2009CN101558058A Modulators of CB1 receptors
10/14/2009CN101558057A 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders
10/14/2009CN101558055A Spiro substituted compounds as angiogenesis inhibitors
10/14/2009CN101558053A Novel inhibitors of chymase
10/14/2009CN101558050A Non-nucleoside reverse transcriptase inhibitors
10/14/2009CN101558049A Substituted pyrazole and triazole compounds as KSP inhibitors
10/14/2009CN101558048A Amino quinazolines derivatives wuth blood platelet reducing properties
10/14/2009CN101558046A Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
10/14/2009CN101558041A Caspase inhibitors based on pyridazinone scaffold
10/14/2009CN101558038A Novel curcumin derivative
10/14/2009CN101557828A Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease
10/14/2009CN101557827A Pharmaceutical compositions comprising HGH for oral delivery
10/14/2009CN101557826A Therapeutic agent for urinary tract disease
10/14/2009CN101557814A Macrocyclic lactone compounds and methods for their use
10/14/2009CN101557813A Liposome treatment of viral infections
10/14/2009CN101557812A Use of 3-alpha-androstanediol, optionally in combination with a pde5 inhibitor, in the treatment of sexual dysfunction
10/14/2009CN101557811A Use of dipeptidyl peptidase IV inhibitors for preventing, delaying or reducing the occurance of edema
10/14/2009CN101557810A Novel 2 -imidazoles as ligands for trace amine associated receptors (taar)
10/14/2009CN101557809A Stabilized synthetic brood pheromone for manipulating the behaviour and physiology of honey bees
10/14/2009CN101557808A Method of treatment for inflammatory bowel disease
10/14/2009CN101557807A Nutritional supplement composition for treatment of ocular diseases
10/14/2009CN101557806A Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases
10/14/2009CN101557804A Phenylalkylamino carbamate compositions
1 ... 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 2556 2557 2558 2559 ... 7860